Contrasting Reliance (NYSE:RS) and Cerebain Biotech (OTCMKTS:CBBT)

Cerebain Biotech (OTCMKTS:CBBT) and Reliance (NYSE:RS) are both industrials companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, valuation and risk.

Valuation & Earnings

This table compares Cerebain Biotech and Reliance”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cerebain Biotech	N/A	N/A	N/A	N/A	N/A
Reliance	$14.29 billion	1.43	$739.40 million	$17.20	23.32

Reliance has higher revenue and earnings than Cerebain Biotech.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Cerebain Biotech and Reliance, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cerebain Biotech	0	0	0	0	0.00
Reliance	1	5	2	1	2.33

Reliance has a consensus target price of $377.50, suggesting a potential downside of 5.90%. Given Reliance’s stronger consensus rating and higher possible upside, analysts clearly believe Reliance is more favorable than Cerebain Biotech.

Insider & Institutional Ownership

79.3% of Reliance shares are owned by institutional investors. 0.4% of Reliance shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Cerebain Biotech and Reliance’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cerebain Biotech	N/A	N/A	N/A
Reliance	5.65%	12.51%	8.47%

Summary

Reliance beats Cerebain Biotech on 10 of the 10 factors compared between the two stocks.

About Cerebain Biotech

Cerebain Biotech Corp. is a biomedical company, which engages in the creation and clinical development of a minimally invasive implantable device. It focuses on the discovery of products for the treatment of Alzheimer’s disease utilizing Omentum. The company was founded on December 18, 2007 and is headquartered in Costa Mesa, CA.

About Reliance

Reliance, Inc. operates as a diversified metal solutions provider and the metals service center company in the United States, Canada, and internationally. The company distributes a line of approximately 100,000 metal products, including alloy, aluminum, brass, copper, carbon steel, stainless steel, titanium, and specialty steel products; and provides metals processing services to general manufacturing, non-residential construction, transportation, aerospace, energy, electronics and semiconductor fabrication, and heavy industries. It sells its products directly to original equipment manufacturers, which primarily include small machine shops and fabricators. The company was formerly known as Reliance Steel & Aluminum Co. and changed its name to Reliance, Inc. in February 2024. Reliance, Inc. was founded in 1939 and is based in Scottsdale, Arizona.